Critical Rights and Rule-of-Law Concern
Trump promoted hydroxychloroquine at least 65 times in White House briefings before studies established it was ineffective and potentially dangerous for COVID. He suggested at an April 23, 2020 briefing that injecting disinfectants might work as treatment and asked officials to study inserting UV light 'inside the body.' Poison control centers reported a spike in calls after the disinfectant comments. The FDA granted hydroxychloroquine an Emergency Use Authorization in March 2020 under White House pressure, then revoked it in June 2020 citing 'serious cardiac adverse events.' Trump campaign donors funded oleander extract studies. His false '35% mortality improvement' claim for convalescent plasma prompted FDA Commissioner Stephen Hahn to issue a correction the same day.